Burning Rock Shares Surge Over 35% as Losses Decrease
Revenue Growth: Burning Rock's revenue increased by 2.3% in the third quarter, primarily driven by a significant rise in R&D services, despite declines in its core cancer diagnostic products.
Stock Performance: The company's stock has tripled this year, with a notable 33% increase following its latest earnings report, reflecting investor optimism about its high gross margins and potential path to profitability.
Financial Challenges: Despite the revenue growth, Burning Rock continues to face high operating expenses, which accounted for 87% of its revenue, leading to a net loss that, while narrowed, still indicates ongoing financial struggles.
Market Position: The company has received approval for some products in Japan as companion diagnostics, but its global revenue remains weak, highlighting the uncertainty surrounding its growth prospects compared to other successful Chinese stocks.
Trade with 70% Backtested Accuracy
Analyst Views on ZEPP

No data
About ZEPP
About the author

- Earnings Report Schedule: Zepp Health is set to announce its first quarter 2026 unaudited financial results on June 8, 2026, highlighting the company's ongoing growth potential in the smart wearables and health technology sectors.
- Conference Call Timing: Management will hold a conference call at 9:30 p.m. ET on June 8, expected to attract significant attention from investors and analysts, thereby enhancing the company's transparency.
- Global User Base: To date, Zepp has shipped over 200 million devices to more than 53 million users worldwide, demonstrating its strong influence and market penetration in the smart health sector.
- Technological Platform Advantage: Leveraging its proprietary Zepp Digital Management Platform, Zepp Health provides 24/7 actionable insights and guidance to help users achieve their health goals, further solidifying its market leadership.
- Earnings Announcement: Zepp Health is set to report its unaudited financial results for Q1 2026 on June 8, 2026, reflecting the company's ongoing growth in the smart wearables and health technology sectors.
- Conference Call Schedule: Management will hold a conference call at 9:30 p.m. ET on June 8, allowing investors to dial in and stay updated on the latest company developments.
- Global User Base: To date, Zepp has shipped over 200 million units to more than 53 million users across over 150 countries, showcasing its significant impact in the smart health market.
- Technological Platform Advantage: Leveraging its proprietary Zepp Digital Management Platform, which integrates AI chips and biometric sensors, Zepp Health provides 24/7 actionable health insights and guidance, further solidifying its market leadership.
- Annual Report Submission: On April 24, 2026, Zepp Health filed its annual report for the year ended December 31, 2025, with the SEC, reflecting the company's ongoing commitment to compliance and transparency, which is crucial for maintaining investor trust.
- Report Access: The annual report will be available on the company's investor relations website and the SEC's site, with shareholders and ADS holders able to request free hard copies, enhancing engagement and communication with investors.
- Market Leadership: Zepp Health stands as a global leader in smart wearables and health technology, leveraging brands like Amazfit, Zepp Clarity, and Zepp Aura to empower users in optimizing their health and fitness journeys, thereby solidifying its market position.
- User Base Expansion: To date, Zepp has shipped over 200 million devices and served more than 53 million users across over 150 countries and regions, demonstrating its extensive global reach and potential for continued growth.
- Financial Performance: Zepp Health reported a loss of $40 million as of December 31, 2025, with a market cap of $235 million, indicating challenges in profitability, yet analysts remain optimistic about its future.
- Breakeven Expectations: Analysts predict that Zepp Health will achieve a profit of $1.5 million in 2026, suggesting that the company is on track to breakeven within the next 12 months, reflecting strong market confidence in its growth potential.
- Growth Rate Requirement: To meet analysts' breakeven forecasts, Zepp Health must achieve an average annual growth rate of 56%, which signals high investor confidence but also highlights potential risks associated with slower growth.
- Debt Levels: Zepp Health's debt constitutes 54% of its equity, exceeding the typical threshold of 40%, which increases investment risk, particularly as the company is not yet profitable.
- Significant Revenue Growth: Zepp Health reported Q4 2025 revenue of $85.2 million, a 43% year-over-year increase, with full-year revenue reaching $259 million, reflecting a 41.8% growth from 2024, indicating strong market performance and sustained growth potential.
- Margin Improvement: The gross margin for Q4 2025 reached 40.4%, expanding by 3.6 percentage points from Q4 2024, demonstrating enhanced pricing power and brand recognition, which will contribute to future profitability.
- Strong Product Sales: Amazfit branded product sales surged by 45.4% in Q4 2025, with a full-year growth of 51%, reflecting robust consumer demand for new products and laying a solid foundation for future market expansion.
- Positive Cash Flow Position: The company reported cash and cash equivalents of $113 million in Q4 2025, showcasing a positive operating cash flow that strengthens its liquidity and ability to navigate market fluctuations.










